SEC Comment Letter for Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704) (CLRB) — Nov 8, 2016
Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704)
Date: Nov. 8, 2016 · CIK: 0001279704 · Accession: 0000000000-16-100103
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-214310
Letter
Mail Stop 4 546 November 7, 2016 James Caruso President and Chief Executive Officer Cellectar Biosciences, Inc. 3301 Agriculture Drive Madison, WI 53716
Re: Cellectar Biosciences, Inc. Registration Statement on Form S-3 Filed October 28 , 201 6 File No. 333-214310
Dear Mr. Caruso :
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
You may contact Scot Foley at (202) 551 -3383 or Mary Beth Breslin at (202) 551 -3625 with any questions.
Sincerely,
/s/ Mary Beth Breslin for
Show Raw Text
Mail Stop 4 546 November 7, 2016 James Caruso President and Chief Executive Officer Cellectar Biosciences, Inc. 3301 Agriculture Drive Madison, WI 53716 Re: Cellectar Biosciences, Inc. Registration Statement on Form S-3 Filed October 28 , 201 6 File No. 333-214310 Dear Mr. Caruso : This is to advise you that we have not reviewed and will not review your registration statement . Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. You may contact Scot Foley at (202) 551 -3383 or Mary Beth Breslin at (202) 551 -3625 with any questions. Sincerely, /s/ Mary Beth Breslin for Suzanne Hayes Assistant Director Office of Healthcare and Insurance cc: Paul Bork, Esq. Foley Hoag LLP